GUARD-AF (A-fib) - Clinical Trial

What is the Purpose of this Study?

Atrial fibrillation/atrial flutter (or Afib) are types of irregular heartbeats that are common in older age. People with Afib can have a higher risk of stroke. We are doing this study is to see if using a device to find undetected Afib lowers the risk of stroke.

What is the Condition Being Studied?

Atrial Fibrillation, Atrial Flutter

Who Can Participate in the Study?

-Aged 70+
-Are on Medicare A & B
-Have no history of atrial fibrillation or atrial flutter
-Don't have a pacemaker or other heart device
-Are not on blood thinners (other than aspirin)

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
-Be randomly assigned (like flipping a coin) to Group 1 or Group 2:
--Group1 will wear a patch heart monitor for 2 weeks
--Group 2 will not wear a monitor and will continue with their regular care
- Allow the study team to review your Medicare claims for up to 5 years to find out if you had a significant health event such as stroke or major bleeding or if you were prescribed a blood thinner.

Study Details

Full Title
GUARD-AF: reducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals
Principal Investigator
Protocol Number
IRB: PRO00104358
NCT: NCT04126486
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698